Companies: 10,795·Total market cap: $144.5T
Black Bird Biotech, Inc.

Black Bird Biotech, Inc.

BBBTOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$98405
P/E Ratio
52W High$0.0001
52W Low$0.0001

Black Bird Biotech, Inc. (BBBT) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

bbbt · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Black Bird Biotech, Inc. (BBBT) measures how much investors pay for each dollar of the company's trailing earnings. BBBT's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.01.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
EPS (TTM)
-$0.01
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Black Bird Biotech, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2006 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Black Bird Biotech, Inc.
Black Bird Biotech, Inc.You
BBBT
$0MN/A-$0.01
Advantis Corp.
Advantis Corp.
ADVT
$0MN/A-$0.00
CannLabs, Inc.
CannLabs, Inc.
CANL
$0M7.48x$0.00
Parallel Industries Inc.
Parallel Industries Inc.
EAPH
$0MN/A-$0.00
The Greater Cannabis Company, Inc.
The Greater Cannabis Company, Inc.
GCAN
$0MN/A-$0.00
Green Rain Energy Holdings Inc.
Green Rain Energy Holdings Inc.
GREH
$0MN/A-$0.00
Novo Integrated Sciences, Inc.
Novo Integrated Sciences, Inc.
NVOS
$0MN/A-$0.89

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 17 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-0.01
2021-12-31
FY2021
$-0.01
2020-12-31
FY2020
$-0.01
2019-12-31
FY2019
$-0.00
2018-12-31
FY2018
$-0.00
2017-12-31
FY2017
$-0.00
2016-12-31
FY2016
$-0.00
2015-12-31
FY2015
$-0.00
2014-12-31
FY2014
$-0.00
2013-12-31
FY2013
$-0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Black Bird Biotech, Inc. (BBBT) measures how much investors pay for each dollar of the company's trailing earnings. BBBT's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.01.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.01 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

BBBT pe ratio · 6 questions

BBBT's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via BBBT's SEC 10-K and 10-Q filings.

BBBT PE ratioWhat is BBBT PE ratioCurrent PE ratio of BBBTBBBT PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Black Bird Biotech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09